Navigation Links
AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain

The Company is considering whether it would be necessary or advisable to study a similar lower dose of quinidine in a second Phase III trial being planned for DPN pain.

About AVANIR

AVANIR Pharmaceuticals is focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases. AVANIR's products and product candidates address therapeutic markets that include the central nervous system, cardiovascular disorders, inflammation and infectious diseases. AVANIR currently markets FazaClo(R), the only orally-disintegrating formulation of clozapine for the management of severely ill schizophrenic patients who fail to respond adequately to standard drug treatments for schizophrenia. FazaClo is also indicated for reducing the risk of suicidal behavior in patients with schizophrenia or schizoaffective disorder. For full prescribing information and important safety information regarding FazaClo, please visit www.fazaclo.com. AVANIR's lead product candidate for the treatment of involuntary emotional expression disorder (IEED), Zenvia, is the subject of an approvable letter from the FDA. Additionally, AVANIR recently completed a Phase III clinical trial with Zenvia in patients with diabetic peripheral neuropathic (DPN) pain where all primary endpoints were met. AVANIR has an ongoing development program with Novartis International Pharmaceutical Ltd. for the treatment of inflammatory disease. The Company's first commercialized product, Abreva(R), is marketed in North America by GlaxoSmithKline Consumer Healthcare and is the leading over-the-counter product for the treatment of cold sores. Further information about AVANIR can be found at www.avanir.com.

Forward Looking Statement

Statements in this press release that are not historical facts, including statements that are preceded by, followed by, or that include such words as "estimate," "intend," "anticipate," "believe," "plan," "goal," "expect," or simila
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. AVANIR Pharmaceuticals to Present Zenvia Phase III Data in Diabetic Peripheral Neuropathic Pain at Second International Congress on Neuropathic Pain
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
Post Your Comments:
(Date:12/17/2009)... -- The Dr. Paul Janssen Award for Biomedical ... The $100,000 Award recognizes individuals whose efforts have ... human health. Nomination forms are available at ... February 15, 2010. The Award winner is chosen ... top scientists, which features three new members this ...
(Date:12/17/2009)... Ill., Dec. 17 Medela announced today ... Milk (breastmilk) Collection Campaign in honor of the ... than 4,100 participated in the campaign, voting for ... the following hospitals will receive $5,000 in neonatal ... Memorial Hospital at Gulfport, Gulfport, MS. ,, * ...
(Date:12/17/2009)... 17 Duane Reade, the largest drug store ... its H1N1 immunization program as part of the Company,s ... New Yorkers and to be a destination for their ... be offered at select Duane Reade pharmacies in the ... by the New York City Department of Health. For ...
Breaking Medicine Technology:Nominations Open for the 2010 Dr. Paul Janssen Award for Biomedical Research 2Nominations Open for the 2010 Dr. Paul Janssen Award for Biomedical Research 3Nominations Open for the 2010 Dr. Paul Janssen Award for Biomedical Research 4Medela Announces Virtual Human Milk Collection Campaign Award Recipients in Honor of 2009 Prematurity Awareness Month 2Duane Reade Announces Plans for H1N1 Immunization Program 2Duane Reade Announces Plans for H1N1 Immunization Program 3QualTech Laboratories Validates USP Protocols for Anti Factor IIa Chromogenic Assay for Potency 4848 1QualTech Laboratories Validates USP Protocols for Anti Factor IIa Chromogenic Assay for Potency 4848 2VJ Day marked with launch of POW project on Merseyside 54315 1VJ Day marked with launch of POW project on Merseyside 54315 2Essential nutrient found in eggs may help lower risk of neural tube defects 9544 1Essential nutrient found in eggs may help lower risk of neural tube defects 9544 2Essential nutrient found in eggs may help lower risk of neural tube defects 9544 3
... 19, 2007 /PRNewswire-FirstCall/ --,Genaera Corporation today announced that ... novel anti-obesity compound,during the American Diabetes Association (ADA) ... , The abstract, # 1801-P, is titled, "Trodusquemine ... Loss, Reduces,Adiposity, and Improves Plasma Insulin and Leptin ...
... VELCADE efficacy in broad range,of patients and across ... 2007 /PRNewswire-FirstCall/ --,Millennium Pharmaceuticals, Inc. today announced that ... single-agent,efficacy for patients with previously treated multiple myeloma,(MM), ... (IMW) in Kos, Greece, June 25-30, 2007. , ...
Other Medicine Technology:Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 2Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 3Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 4Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 2Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 3Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 4Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 5Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 6Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 7Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 8
(Date:12/17/2009)... A pregnant woman, who has carefully examined her options for birth ... – realizes that her healthcare provider is not accustomed to providing ... match her provider’s practice style. , ... Silver Spring, ... pregnant woman, who has carefully examined her options for birth – ...
(Date:12/17/2009)... discount certificate to introduce the wonders of youthful rejuvenation ... ... R. Raval, MD, FACS, a Denver plastic surgeon who operates both ... Creek North, is offering an online Holiday Aesthetics Special. Go to ... services or products for just $75., , ,The ability to purchase ...
(Date:12/17/2009)... we don,t know about the secret measures could prove ... -- A leading advocacy group for small businesses said ... define health care reform in the Senate is not ... undermines the confidence that is desperately needed to get ... According to the Small Business & Entrepreneurship Council (SBE ...
(Date:12/17/2009)... Blue Cross Blue Shield of Michigan announced today that ... and BCN,s current vice president for products and marketing, ... largest health maintenance organization when Carlson retires at the ... today by Daniel J. Loepp, president and CEO of ... appointment is pending formal approval from the BCBSM and ...
(Date:12/17/2009)... city is calling itself, that is, Copenhagen in ... change. Narconon has its European management headquarters here, ... Narconon drug education and rehabilitation network is ... the streets thrum with student drums and Politi ... lights - a youth protest group threatens to ...
Breaking Medicine News(10 mins):Health News:Who Should Deliver Your Baby? New Tool Helps Expectant Parents Choose Their Health Care Provider 2Health News:Who Should Deliver Your Baby? New Tool Helps Expectant Parents Choose Their Health Care Provider 3Health News:Holiday Aesthetics Special is Ageless Beauty Gift from Denver's Dr. Raval 2Health News:Holiday Aesthetics Special is Ageless Beauty Gift from Denver's Dr. Raval 3Health News:The Reid Bill and What We Know: Higher Taxes and Less Capital - Higher Health Costs and Red Tape for Small Business 2Health News:Save the Planet. Stop Smoking Dope, Says Narconon 2
... Residents Invited to VFW from 7:00 - 9:00 p.m. ... sample collection and testing currently taking place in homes, ... a reminder to the city,s residents - and others ... damage resulting from corporate environmental contamination can be catastrophic. ...
... Fla. , May 18 Recognized as ... billion Picture Archiving Communications Systems (PACS) market, and ... Leadership Award for Cardiovascular PACS" (CVPACS), and recognized ... Thinking Systems Corporation develops and markets the industry,s ...
... CYBX ) today announced that Bryan D. ... on May 18, 2009. Dr. Olin will lead ... Cyberonics from Zeltiq Aesthetics, an aesthetics device firm in ... since October 2007. Prior to Zeltiq, Dr. Olin ...
... USANA Health ... ) launched a nationwide geocaching event today to promote ... is a tea-based beverage, containing antioxidants and other important ... the Multimedia News Release, go to: http://www.prnewswire.com/mnr/drinkrev3/38461/ ...
... /PRNewswire-USNewswire/ -- ACORN CRO, an oncology-focused CRO, ... And Recruitment). The introduction of this dedicated technology tool ... the study feasibility process. "STAR was developed under the ... to save valuable time during the study start-up phase. ...
... Bell Environmental Services (BES) , a full-service pest management ... a travel bed bug kit to help abate the ... travelers and anyone traveling away from home.Photo: ... contains a 6 ounce bed bug control luggage ...
Other Medicine News:Health News:Town Hall Meeting to Be Held on Wednesday, May 20, 2009 to Educate and Empower Garfield Residents on Medical and Legal Issues Related to Chromium Contamination 2Health News:Thinking Systems to Showcase the Company's Upgraded ThinkingPACS(TM) and ThinkingRIS(TM) Solutions 2Health News:Cyberonics Names Bryan D. Olin, Ph.D. Vice President, Quality 2Health News:Photos: USANA Launches National Rev3 Geocaching Challenge 2Health News:ACORN CRO Launches STAR (Site Tracking and Recruitment) 2Health News:Travel Bed Bug Kit Available for 2009 Summer Travel Season 2
... accurate lesion assessment plays a ... the appropriate stent size and ... (IC3D), a highly precise three-dimensional ... now able to quickly quantify ...
... dTC is a versatile solution designed to ... from preparation to diagnosis and therapy, ... AXIOM Artis dTC, your cath lab becomes ... that leaves you free to concentrate on ...
... AXIOM Artis FC is a ... with flexible system architecture for ... interventions. The flexible and ergonomic ... optimally adapt the system configuration ...
The ACUSON Sequoia C512 system elevates imaging and Doppler performance through new, high-density acoustic sampling, precise control of the transmitted acoustic waveform, and new transducer technolog...
Medicine Products: